SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that Lucy Shapiro, Ph.D., a renowned molecular microbiologist at Stanford University, has been elected to its board of directors. Gen-Probe's board now has eight members, including seven who are not Gen-Probe employees.
"We are delighted to add Lucy's expertise, intelligence and enthusiasm to an already strong Gen-Probe board, and we look forward to her making substantial contributions from day one," said Hank Nordhoff, the Company's chairman and chief executive officer.
Dr. Shapiro, 67, is the Virginia and D.K. Ludwig professor of cancer research, associate chair of the department of Developmental Biology, and director of the Beckman Center for Molecular and Genetic Medicine at Stanford University's School of Medicine. She is a senior fellow at the Institute for International Studies at Stanford and a fellow of the American Association for the Advancement of Sciences.
Dr. Shapiro is a co-founder and director of Anacor Pharmaceuticals, a biopharmaceutical company developing novel small-molecule therapeutics to treat infectious and inflammatory diseases. She is also co-chair of the company's scientific advisory board. She was a non-executive director of GlaxoSmithKline from 2001 to 2006.
Dr. Shapiro has been elected to the National Academy of Sciences, the
American Academy of Microbiology, the American Academy of Arts and
Sciences, and the Institute of Medicine of the National Academy of Sciences
for her work in the fields of molecular biology and microbiology. She
received the Selman Waksman Award from the National Academy of Sciences in
2005. She received a B.A. from Brooklyn College and a Ph.D. in Molecular
|SOURCE Gen-Probe Incorporated|
Copyright©2008 PR Newswire.
All rights reserved